Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biohaven Ltd
(NY:
BHVN
)
53.47
+0.38 (+0.72%)
Official Closing Price
Updated: 7:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biohaven Ltd
< Previous
1
2
3
4
5
6
7
8
9
Next >
Scholar Rock Catapults By Triple Digits On Final-Phase Win In Spinal Muscular Atrophy
October 07, 2024
The company is hoping to treat patients with spinal muscular atrophy, a muscle-wasting disease.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 07, 2024
Via
Benzinga
Acuity Brands, Nike And 3 Stocks To Watch Heading Into Tuesday
October 01, 2024
Via
Benzinga
Hewlett Packard Enterprise, Nvidia, Progress Software And Other Big Stocks Moving Higher On Wednesday
September 25, 2024
Via
Benzinga
Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
September 24, 2024
Biohaven, a clinical-stage biopharmaceutical company, is attracting investors with promising results for its experimental drug.
Via
MarketBeat
BHVN Stock Earnings: Biohaven Misses EPS for Q2 2024
August 09, 2024
BHVN stock results show that Biohaven missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
BHVN Stock Earnings: Biohaven Misses EPS for Q1 2024
May 09, 2024
BHVN stock results show that Biohaven missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Dow Gains Over 50 Points; Elevai Labs Shares Plummet
September 23, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Via
Benzinga
Crude Oil Down Over 1%; US Manufacturing PMI Falls In September
September 23, 2024
Via
Benzinga
Exposures
Fossil Fuels
Biohaven Stock Spikes After Drug Candidate To Treat Rare Neurodegenerative Disease Shows Promise
September 23, 2024
Biohaven announced topline results from its pivotal Study BHV4157-206-RWE, showing that troriluzole significantly slowed disease progression in spinocerebellar ataxia patients over three years. The...
Via
Benzinga
Exposures
Product Safety
Biohaven, Tesla And Other Big Stocks Moving Higher On Monday
September 23, 2024
Via
Benzinga
Biohaven Surges After Delaying Progression By Up To 70% In A Rare Disease
September 23, 2024
The company is hoping to soon file for approval of what could be the first SCA treatment.
Via
Investor's Business Daily
This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
September 16, 2024
Via
Benzinga
Biohaven Stock Earns Relative Strength Rating Upgrade
August 21, 2024
Biohaven stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 88 to 91.
Via
Investor's Business Daily
$1M Bet On Biohaven? Check Out These 3 Stocks Insiders Are Buying
July 22, 2024
Via
Benzinga
The 3 Smartest Healthcare Stocks to Buy With $1K Right Now
June 28, 2024
The healthcare stocks to buy deserve more respect from investors who seek top-level growth outside of the tech sector.
Via
InvestorPlace
HP Posts Upbeat Earnings, Joins Foot Locker, American Superconductor, Red Robin Gourmet Burgers And Other Big Stocks Moving Higher On Thursday
May 30, 2024
Via
Benzinga
After Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay
May 30, 2024
Immunovant, which jumped Wednesday on news from rival Biohaven, reversed course Thursday.
Via
Investor's Business Daily
Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
May 29, 2024
Biohaven shares drop as interim data from the Phase 1 study of BHV-1300 fell short of investor expectations.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 29, 2024
Via
Benzinga
What's Going On With Biohaven Stock Wednesday?
May 29, 2024
The company announced it dosed a patient with a new possible treatment for certain cancers, showcased positive data from two different studies and presented other updates.
Via
Benzinga
Biohaven Crashes After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump
May 29, 2024
The company says it's still running additional testing of the drug, calling the results "positive."
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 29, 2024
Via
Benzinga
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
May 21, 2024
The Structure Therapeutics stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the stock a significant upside potential.
Via
Benzinga
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
May 14, 2024
Via
Benzinga
Crocs To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
May 13, 2024
Via
Benzinga
Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar
May 01, 2024
These biotech stocks seem to be rich with intriguing growth plays going for very reasonable multiples this May.
Via
InvestorPlace
Around $1M Bet On Biohaven? Check Out These 4 Stocks Insiders Are Buying
April 26, 2024
Via
Benzinga
3 Biotech Stocks to Buy on the Dip: April 2024
April 26, 2024
With medical innovation being a resilient space, investors can have confidence with these biotech stocks to buy on the dip.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.